|
CL2025003861A1
(es)
|
|
Formulaciones farmacéuticas de un agonista del receptor de amilina y un agonista del receptor de glp-1 que comprenden una ciclodextrina.
|
|
BR102022025291A2
(https=)
|
|
|
|
BR102023010976A2
(https=)
|
|
|
|
BR102023008688A2
(https=)
|
|
|
|
BR102023007252A2
(https=)
|
|
|
|
BR102023005164A2
(https=)
|
|
|
|
BR102023001877A2
(https=)
|
|
|
|
BR102023000289A2
(https=)
|
|
|
|
BR102022026909A2
(https=)
|
|
|
|
BR102022023461A2
(https=)
|
|
|
|
BY13160U
(https=)
|
|
|
|
BY13165U
(https=)
|
|
|
|
BY13158U
(https=)
|
|
|
|
CN307044742S
(https=)
|
|
|
|
CN307045880S
(https=)
|
|
|
|
CN307044309S
(https=)
|
|
|
|
CN307046064S
(https=)
|
|
|
|
CN307047206S
(https=)
|
|
|
|
BY23987C1
(https=)
|
|
|
|
BY23966C1
(https=)
|
|
|
|
BY23965C1
(https=)
|
|
|
|
BY13176U
(https=)
|
|
|
|
BY13175U
(https=)
|
|
|
|
BY13174U
(https=)
|
|
|
|
BY13170U
(https=)
|
|
|